Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC

Clinical trial NCT05007587 · UNKNOWN

Trial details

NCT number: NCT05007587
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Stage IIIa

Start date: 2021-07-01
Primary completion: 2022-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.